Golden has been acquired by ComplyAdvantage.Read about it here ⟶

List of Aileron Therapeutics patents

Patents where

Current Assignee

Name

Aileron Therapeutics

Name	Description	Patent Applicant	Current Assignee	Patent Jurisdiction	Patent Number	Date of Patent
‌ US Patent 8927500 Peptidomimetic macrocycles	Patent 8927500 was granted and assigned to Aileron Therapeutics on January, 2015 by the United States Patent and Trademark Office.	Aileron Therapeutics	Aileron Therapeutics	United States Patent and Trademark Office	8927500	January 6, 2015
‌ US Patent 9505804 Peptidomimetic macrocycles	Patent 9505804 was granted and assigned to Aileron Therapeutics on November, 2016 by the United States Patent and Trademark Office.	Aileron Therapeutics	Aileron Therapeutics	United States Patent and Trademark Office	9505804	November 29, 2016
‌ US Patent 8637686 Triazole macrocycle systems	Patent 8637686 was granted and assigned to Aileron Therapeutics on January, 2014 by the United States Patent and Trademark Office.		Aileron Therapeutics	United States Patent and Trademark Office	8637686	January 28, 2014
‌ US Patent 8071541 Methods for preparing internally constrained peptides and peptidomimetics	Patent 8071541 was granted and assigned to Aileron Therapeutics on December, 2011 by the United States Patent and Trademark Office.		Aileron Therapeutics	United States Patent and Trademark Office	8071541	December 6, 2011
‌ US Patent 9175045 Peptidomimetic macrocycles	Patent 9175045 was granted and assigned to Aileron Therapeutics on November, 2015 by the United States Patent and Trademark Office.	Aileron Therapeutics	Aileron Therapeutics	United States Patent and Trademark Office	9175045	November 3, 2015
‌ US Patent 7981999 Triazole macrocycle systems	Patent 7981999 was granted and assigned to Aileron Therapeutics on July, 2011 by the United States Patent and Trademark Office.		Aileron Therapeutics	United States Patent and Trademark Office	7981999	July 19, 2011
‌ US Patent 9522947 Peptidomimetic macrocycles	Patent 9522947 was granted and assigned to Aileron Therapeutics on December, 2016 by the United States Patent and Trademark Office.	Aileron Therapeutics	Aileron Therapeutics	United States Patent and Trademark Office	9522947	December 20, 2016
‌ US Patent 10300109 Peptidomimetic macrocycles	Patent 10300109 was granted and assigned to Aileron Therapeutics on May, 2019 by the United States Patent and Trademark Office.	Aileron Therapeutics	Aileron Therapeutics	United States Patent and Trademark Office	10300109	May 28, 2019
‌ US Patent 9096684 Peptidomimetic macrocycles	Patent 9096684 was granted and assigned to Aileron Therapeutics on August, 2015 by the United States Patent and Trademark Office.	Aileron Therapeutics	Aileron Therapeutics	United States Patent and Trademark Office	9096684	August 4, 2015
‌ US Patent 10905739 Peptidomimetic macrocycles and formulations thereof	Patent 10905739 was granted and assigned to Aileron Therapeutics on February, 2021 by the United States Patent and Trademark Office.	Aileron Therapeutics	Aileron Therapeutics	United States Patent and Trademark Office	10905739	February 2, 2021
‌ US Patent 7981998 Bis-sulfhydryl macrocyclization systems	Patent 7981998 was granted and assigned to Aileron Therapeutics on July, 2011 by the United States Patent and Trademark Office.		Aileron Therapeutics	United States Patent and Trademark Office	7981998	July 19, 2011
‌ US Patent 7960506 Bis-sulfhydryl macrocyclization systems	Patent 7960506 was granted and assigned to Aileron Therapeutics on June, 2011 by the United States Patent and Trademark Office.		Aileron Therapeutics	United States Patent and Trademark Office	7960506	June 14, 2011
‌ US Patent 8399405 Peptidomimetic macrocycles	Patent 8399405 was granted and assigned to Aileron Therapeutics on March, 2013 by the United States Patent and Trademark Office.		Aileron Therapeutics	United States Patent and Trademark Office	8399405	March 19, 2013
‌ US Patent 10059741 Peptidomimetic macrocycles	Patent 10059741 was granted and assigned to Aileron Therapeutics on August, 2018 by the United States Patent and Trademark Office.	Aileron Therapeutics	Aileron Therapeutics	United States Patent and Trademark Office	10059741	August 28, 2018
‌ US Patent 10030049 Triazole macrocycle systems	Patent 10030049 was granted and assigned to Aileron Therapeutics on July, 2018 by the United States Patent and Trademark Office.	Aileron Therapeutics	Aileron Therapeutics	United States Patent and Trademark Office	10030049	July 24, 2018
‌ US Patent 10023613 Peptidomimetic macrocycles as modulators of MCL-1	Patent 10023613 was granted and assigned to Aileron Therapeutics on July, 2018 by the United States Patent and Trademark Office.	Aileron Therapeutics	Aileron Therapeutics	United States Patent and Trademark Office	10023613	July 17, 2018
‌ US Patent 10246491 Peptidomimetic macrocycles and use thereof in regulating HIF1alpha	Patent 10246491 was granted and assigned to Aileron Therapeutics on April, 2019 by the United States Patent and Trademark Office.	Aileron Therapeutics	Aileron Therapeutics	United States Patent and Trademark Office	10246491	April 2, 2019
‌ US Patent 10308699 Peptidomimetic macrocycles	Patent 10308699 was granted and assigned to Aileron Therapeutics on June, 2019 by the United States Patent and Trademark Office.	Aileron Therapeutics	Aileron Therapeutics	United States Patent and Trademark Office	10308699	June 4, 2019
‌ US Patent 9175047 Peptidomimetic macrocycles	Patent 9175047 was granted and assigned to Aileron Therapeutics on November, 2015 by the United States Patent and Trademark Office.		Aileron Therapeutics	United States Patent and Trademark Office	9175047	November 3, 2015
‌ US Patent 8808694 Therapeutic peptidomimetic macrocycles	Patent 8808694 was granted and assigned to Aileron Therapeutics on August, 2014 by the United States Patent and Trademark Office.		Aileron Therapeutics	United States Patent and Trademark Office	8808694	August 19, 2014
‌ US Patent 10213477 Peptidomimetic macrocycles	Patent 10213477 was granted and assigned to Aileron Therapeutics on February, 2019 by the United States Patent and Trademark Office.	Aileron Therapeutics	Aileron Therapeutics	United States Patent and Trademark Office	10213477	February 26, 2019
‌ US Patent 10967042 Peptidomimetic macrocycles	Patent 10967042 was granted and assigned to Aileron Therapeutics on April, 2021 by the United States Patent and Trademark Office.	Aileron Therapeutics	Aileron Therapeutics	United States Patent and Trademark Office	10967042	April 6, 2021
‌ US Patent 10669230 Disubstituted amino acids and methods of preparation and use thereof	Patent 10669230 was granted and assigned to Aileron Therapeutics on June, 2020 by the United States Patent and Trademark Office.	Aileron Therapeutics	Aileron Therapeutics	United States Patent and Trademark Office	10669230	June 2, 2020
‌ US Patent 10253067 Peptidomimetic macrocycles and uses thereof	Patent 10253067 was granted and assigned to Aileron Therapeutics on April, 2019 by the United States Patent and Trademark Office.	Aileron Therapeutics	Aileron Therapeutics	United States Patent and Trademark Office	10253067	April 9, 2019
‌ US Patent 10703780 Peptidomimetic macrocycles		Aileron Therapeutics	Aileron Therapeutics	United States Patent and Trademark Office	10703780	July 7, 2020

Results per page:

44 results

0 selected

44 results

0 selected